DR. JOHN NAGI KHEIR, M.D.
Medical Practice at Longwood Ave, Boston, MA
License number
Massachusetts 227291
Category
Medical Practice
Type
Pediatric Critical Care Medicine
Address
Address
300 Longwood Ave, Boston, MA 02115
Phone
(617) 355-7327
(617) 734-0453 (Fax)
(617) 734-0453 (Fax)
Personal information
See more information about JOHN NAGI KHEIR at radaris.comName
Address
Phone
5 Lexington St #2, Charlestown, MA 02129
250 1St St, Charlestown, MA 02129
250 1St Ave, Charlestown, MA 02129
5 Lexington St, Charlestown, MA 02129
Charlestown, MA
Professional information
Dr. John N Kheir, Boston MA - MD (Doctor of Medicine)
Specialties:
Pediatric Critical Care Medicine
Age:
47
Address:
300 Longwood Ave, Boston 02115
(617) 355-6286 (Phone), (617) 738-6289 (Fax)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
(617) 355-6286 (Phone), (617) 738-6289 (Fax)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
Certifications:
Pediatric Critical Care Medicine, 2010, Pediatrics, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Univ Of Va Sch Of Med Hlth Sys
Graduated: 2002
Cincinnati Childrens Hospital Medical Center
Children'S Hospital Boston
Univ Of Va Sch Of Med Hlth Sys
Graduated: 2002
Cincinnati Childrens Hospital Medical Center
Children'S Hospital Boston
John Nagi Kheir, Boston MA
Specialties:
Pediatrics, Pediatric Critical Care Medicine, Pediatric Cardiology, Critical Care Medicine
Work:
Univ. of Minnesota Medical Center
300 Longwood Ave, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115
Education:
University of Virginia (2002)
John Nagi Kheir, Boston MA
Specialties:
Pediatric Critical Care Specialist
Address:
300 Longwood Ave, Boston, MA 02115
Education:
Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Critical Care Medicine (Pediatrics)
Microbubbles And Methods For Oxygen Delivery
US Patent:
2012015, Jun 21, 2012
Filed:
Feb 22, 2012
Appl. No.:
13/402409
Inventors:
John Kheir - Brighton MA, US
Mark Andrew Borden - New York NY, US
Francis X. McGowan - Wellesley Hills MA, US
Mark Andrew Borden - New York NY, US
Francis X. McGowan - Wellesley Hills MA, US
Assignee:
The Trustees of Columbia University - New York NY
International Classification:
A61K 9/14, A61P 9/10, A61P 9/00, A61K 33/00, A61P 7/00
US Classification:
424489, 424613
Abstract:
Compositions containing a carrier and microbubbles encapsulating one or more gases, preferably oxygen, and methods for making and using the compositions are described herein. The microbubbles contain a lipid envelope. The compositions may be administered to a patient to quickly deliver large amounts of oxygen to the patient's blood supply or directly to a tissue in need of oxygen. The compositions may be administered via injection or as a continuous infusion. The compositions contain a concentrated microbubble suspension, where the suspension contains at least 40 mL oxygen/dL suspension. The microbubbles are preferably less than 20 microns in diameter, more preferably less than 15 microns in diameter. The microbubbles described herein may be administered to a patient in an effective amount to increase in oxygen concentration in the patient's blood, and/or one or more tissues or organs.
Microbubbles And Methods For Oxygen Delivery
US Patent:
2009019, Jul 30, 2009
Filed:
Sep 29, 2008
Appl. No.:
12/240704
Inventors:
John Kheir - Brighton MA, US
Mark Andrew Borden - New York NY, US
Francis X. McGowan - Wellesley Hills MA, US
Mark Andrew Borden - New York NY, US
Francis X. McGowan - Wellesley Hills MA, US
Assignee:
Children's Medical Center Corporation - Massachusetts MA
The Trustees of Columbia University in the City of New York - New York NY
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 33/00, A61P 9/00, A61K 9/00
US Classification:
424400, 514789
Abstract:
Compositions containing a carrier and microbubles encapsulating one or more gases, preferably oxygen, and methods for making and using the compositions are described herein. The microbubbles contain a lipid envelope formed of at least one base lipid and at least one emulsifying agent. The compositions may be administered to a patient to quickly deliver large amounts of oxygen to the patient's blood supply or directly to a tissue in need of oxygen. The compositions may be administered via injection or as a continuous infusion. The compositions contain a concentrated microbubble suspension, where the suspension contains at least 40 mL oxygen/dL suspension. The microbubbles are preferably less than 20 microns in diameter, more preferably less than 15 microns in diameter. The microbubbles described herein may be administered to a patient in an effective amount to increase in oxygen concentration in the patient's blood, and/or one or more tissues or organs. The microbubbles may be administered alone or in combination with other treatments as an adjuctive therapy.
Gas-Filled Microbubbles And Systems For Gas Delivery
US Patent:
2014001, Jan 9, 2014
Filed:
Nov 11, 2011
Appl. No.:
13/884658
Inventors:
John Kheir - Boston MA, US
Francis X. McGowan - Charleston SC, US
Andrew Loxley - Bethlehem PA, US
Robert Lee - Bethlehem PA, US
Francis X. McGowan - Charleston SC, US
Andrew Loxley - Bethlehem PA, US
Robert Lee - Bethlehem PA, US
Assignee:
Children's Medical Center Corporation - Boston MA
International Classification:
A61K 9/50, A61M 5/19, A61B 5/029, A61M 16/00, A61K 33/00, A01N 1/02
US Classification:
424400, 424613, 435 11, 435 2, 600526, 12820024
Abstract:
Compressible and concentrated suspensions containing gas-filled microbubbles, uses thereof for delivering gas into a subject in need thereof, and systems for delivering the compressible suspensions. The gas-filled microbubbles each comprise a gas core surrounded by a lipid membrane, which includes (a) one or more lipids, such as 1,2-disteroyl-sn-glycero-3-phosphocholine (DSPC) or dipalmitoylphosphatidylcholine (DPPC), and (b) one or more stabilizing detergents, such as poloxamer 188, Pluronic F108, Pluronic F127, polyoxyethylene (100) stearyl ether, cholesterol, gelatin, polyvinylpyrrolidone (PVP), and sodium deoxycholate (NaDoc).